当前位置:首页 - 行情中心 - 翰宇药业(300199) - 财务分析

翰宇药业

(300199)

  

流通市值:130.59亿  总市值:163.31亿
流通股本:7.06亿   总股本:8.83亿

翰宇药业(300199)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.69亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益66638.62万元,未分配利润-178049.76万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产303804.56万元,负债237165.94万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入309,969,965.34590,199,011.64375,225,390.5255,720,574.14
营业总成本231,507,233.07708,040,579.18459,578,775.38309,314,966.43
营业利润76,444,987.52-161,386,422.37-26,228,246.69-2,716,192.76
利润总额76,345,940.73-162,412,259.29-27,593,945.61-3,817,360.58
净利润69,439,025.34-180,091,957.93-35,828,756.23-10,971,389.79
其他综合收益-99,383.361,864,588.58-713,914.14644,068.57
综合收益总额69,339,641.98-178,227,369.35-36,542,670.37-10,327,321.22
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计494,618,808.48463,048,006.84548,032,020.7452,438,180.12
非流动资产合计2,543,426,762.222,545,177,633.252,569,086,743.842,577,364,643.31
资产总计3,038,045,570.73,008,225,640.093,117,118,764.543,029,802,823.43
流动负债合计1,591,998,857.861,424,553,168.651,285,645,1191,072,981,322.35
非流动负债合计779,660,558.84986,625,959.421,101,058,449.871,176,843,372.06
负债合计2,371,659,416.72,411,179,128.072,386,703,568.872,249,824,694.41
归属于母公司股东权益合计648,395,821.48578,626,837.31706,930,696.43754,040,259.98
股东权益合计666,386,154597,046,512.02730,415,195.67779,978,129.02
负债和股东权益合计3,038,045,570.73,008,225,640.093,117,118,764.543,029,802,823.43
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计202,910,272.01766,211,441.71501,843,341.73305,983,944.77
经营活动现金流出小计162,484,976.69601,505,781.16413,773,728.7272,999,341.68
经营活动产生的现金流量净额40,425,295.32164,705,660.5588,069,613.0332,984,603.09
投资活动现金流入小计3,746,209.951,646,205.2546,140,700.2446,040,700.24
投资活动现金流出小计34,282,205.58121,655,382.874,866,778.3246,709,614.21
投资活动产生的现金流量净额-30,535,995.68-70,009,177.55-28,726,078.08-668,913.97
筹资活动现金流入小计70,000,0001,531,683,185.231,241,333,185.23844,905,092.88
筹资活动现金流出小计120,077,959.581,877,160,686.721,507,182,727.291,151,507,496.64
筹资活动产生的现金流量净额-50,077,959.58-345,477,501.49-265,849,542.06-306,602,403.76
汇率变动对现金及现金等价物的影响1,595,530.553,377,635.211,998,721.311,889,111.81
现金及现金等价物净增加额-38,593,129.39-247,403,383.28-204,507,285.8-272,397,602.83
期末现金及现金等价物余额53,939,713.7792,532,843.16135,428,940.6467,538,623.61
TOP↑